NZ223410A - Saturated fatty acid amides as inhibitors of acyl-coa: cholesterol acyltransferase - Google Patents

Saturated fatty acid amides as inhibitors of acyl-coa: cholesterol acyltransferase

Info

Publication number
NZ223410A
NZ223410A NZ223410A NZ22341088A NZ223410A NZ 223410 A NZ223410 A NZ 223410A NZ 223410 A NZ223410 A NZ 223410A NZ 22341088 A NZ22341088 A NZ 22341088A NZ 223410 A NZ223410 A NZ 223410A
Authority
NZ
New Zealand
Prior art keywords
coa
saturated fatty
acyl
inhibitors
fatty acid
Prior art date
Application number
NZ223410A
Other languages
English (en)
Inventor
M L Hoefle
A Holmes
B D Roth
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NZ223410A publication Critical patent/NZ223410A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
NZ223410A 1987-02-24 1988-02-04 Saturated fatty acid amides as inhibitors of acyl-coa: cholesterol acyltransferase NZ223410A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/017,960 US4716175A (en) 1987-02-24 1987-02-24 Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase

Publications (1)

Publication Number Publication Date
NZ223410A true NZ223410A (en) 1989-11-28

Family

ID=21785503

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ223410A NZ223410A (en) 1987-02-24 1988-02-04 Saturated fatty acid amides as inhibitors of acyl-coa: cholesterol acyltransferase

Country Status (17)

Country Link
US (1) US4716175A (cg-RX-API-DMAC10.html)
EP (1) EP0283742B1 (cg-RX-API-DMAC10.html)
JP (1) JPH07121895B2 (cg-RX-API-DMAC10.html)
KR (1) KR880009933A (cg-RX-API-DMAC10.html)
AT (1) ATE89814T1 (cg-RX-API-DMAC10.html)
CA (1) CA1336913C (cg-RX-API-DMAC10.html)
DE (1) DE3881249T2 (cg-RX-API-DMAC10.html)
DK (1) DK165406C (cg-RX-API-DMAC10.html)
ES (1) ES2056843T3 (cg-RX-API-DMAC10.html)
FI (1) FI89593C (cg-RX-API-DMAC10.html)
HK (1) HK148195A (cg-RX-API-DMAC10.html)
IE (1) IE59998B1 (cg-RX-API-DMAC10.html)
MX (1) MX9203139A (cg-RX-API-DMAC10.html)
NO (1) NO174043C (cg-RX-API-DMAC10.html)
NZ (1) NZ223410A (cg-RX-API-DMAC10.html)
PT (1) PT86811B (cg-RX-API-DMAC10.html)
ZA (1) ZA88604B (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827152D0 (en) * 1988-11-21 1988-12-29 Wellcome Found Anti-atherosclerotic diaryl compounds
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
MX22406A (es) * 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).
AU6659090A (en) * 1989-11-16 1991-06-13 Warner-Lambert Company Acat inhibitors
WO1991015464A1 (en) * 1990-04-11 1991-10-17 Warner-Lambert Company Amide ester acat inhibitors
US5149709A (en) * 1990-07-03 1992-09-22 Schering Corporation Inhibitors of acyl-coenzyme A: cholesterol acyl transferase
DE69128630T2 (de) * 1990-07-25 1998-04-23 Teijin Ltd Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
KR0169501B1 (ko) * 1990-11-26 1999-03-20 우에하라 아키라 아닐리드 유도체
FR2673625B1 (fr) * 1991-03-08 1993-05-07 Adir Nouveaux derives d'acylaminophenol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5420164A (en) * 1991-04-04 1995-05-30 Yoshitomi Pharmaceutical Industries, Ltd. Cycloalkylurea compounds
EP0619312A4 (en) * 1991-12-25 1995-07-19 Taisho Pharmaceutical Co Ltd ANILIDE DERIVATIVES.
EP0642498A1 (en) * 1992-05-28 1995-03-15 Pfizer Inc. NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT)
JP3612328B2 (ja) * 1992-07-20 2005-01-19 エーザイ株式会社 ベンゼン誘導体
US5321031A (en) * 1992-09-23 1994-06-14 Schering Corporation 1,2-disubstituted ethyl amides as inhibitors of ACAT
CA2107196A1 (en) * 1992-09-29 1994-03-30 Mitsubishi Chemical Corporation Carboxamide derivatives
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5534529A (en) * 1993-06-30 1996-07-09 Sankyo Company, Limited Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5596001A (en) * 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
IT1265209B1 (it) * 1993-11-22 1996-10-31 Pierrel Spa Difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
EP0726247B1 (en) * 1995-02-08 1998-07-08 Nippon Shoji Kaisha, Limited Aniline derivatives having a polyunsaturated fatty acid residue and use thereof
UA75345C2 (en) * 2000-02-02 2006-04-17 Warner Lambert Co Pharmaceutical composition for topical use intended for treating sebaceous gland disorders and methods of treating acnes using this composition
CN1636000A (zh) * 2000-03-16 2005-07-06 神经能质公司 5-取代芳基嘧啶类
US20040072903A1 (en) * 2001-05-08 2004-04-15 Auerbach Bruce Jeffrey Carboxyalkylether-acat inhibitors combinations
EP1281399A3 (en) * 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
JP5697296B2 (ja) 2004-03-05 2015-04-08 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 高脂血症および高コレステロール血症に関連する障害または疾患を、副作用を最小限にしつつ処置するための方法
TW200831497A (en) * 2006-10-12 2008-08-01 Epix Delaware Inc Carboxamide compounds and their use
BRPI0820701A2 (pt) 2007-12-11 2015-06-16 Cytopathfinder Inc Composto de carboxamida e seu uso como agonistas do receptor de quimiocina
WO2010039801A2 (en) 2008-10-02 2010-04-08 The J. David Gladstone Institutes Methods of treating hepatitis c virus infection
CN116322682A (zh) 2020-07-29 2023-06-23 艾米琳制药有限责任公司 在治疗儿科患者的高脂血症和高胆固醇血症的方法中使用的洛美他派

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL238088A (cg-RX-API-DMAC10.html) * 1958-04-14
BE620639A (cg-RX-API-DMAC10.html) * 1961-07-25
SE353319B (cg-RX-API-DMAC10.html) * 1964-08-15 1973-01-29 Sumitomo Chemical Co
DE1618959C3 (de) * 1967-10-04 1978-12-14 Sumitomo Chemical Co., Ltd., Osaka (Japan) Fettsäureamide und Verfahren zu ihrer Herstellung
DE2830351A1 (de) * 1978-07-11 1980-01-24 Consortium Elektrochem Ind Acylanilide
GR69292B (cg-RX-API-DMAC10.html) * 1979-06-25 1982-05-13 May & Baker Ltd
BR8106184A (pt) * 1980-01-25 1981-11-24 Reanal Finomvegyszergyar Processo para preparacao de derivados de n-aril-n'-(mono-ou dissubstituido)-ureia
NZ216253A (en) * 1985-05-27 1989-07-27 Mitsui Toatsu Chemicals N-(3-chloro-4-isopropylphenyl)-carboxamide derivatives and herbicidal compositions
MA20552A1 (fr) * 1985-10-11 1986-07-01 Pan Medica Sa Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations

Also Published As

Publication number Publication date
DK165406B (da) 1992-11-23
EP0283742A2 (en) 1988-09-28
DE3881249T2 (de) 1993-09-16
NO174043C (no) 1994-03-09
FI89593B (fi) 1993-07-15
PT86811B (pt) 1992-05-29
CA1336913C (en) 1995-09-05
NO174043B (no) 1993-11-29
DK94188D0 (da) 1988-02-23
KR880009933A (ko) 1988-10-05
EP0283742B1 (en) 1993-05-26
JPS63253060A (ja) 1988-10-20
DK94188A (da) 1988-08-25
JPH07121895B2 (ja) 1995-12-25
FI89593C (fi) 1993-10-25
PT86811A (pt) 1988-03-01
NO880774L (no) 1988-08-25
ZA88604B (en) 1989-09-27
MX9203139A (es) 1992-07-01
FI880796A0 (fi) 1988-02-19
IE880204L (en) 1988-08-24
AU1135488A (en) 1988-08-25
NO880774D0 (no) 1988-02-23
ES2056843T3 (es) 1994-10-16
US4716175B1 (cg-RX-API-DMAC10.html) 1993-06-22
FI880796A7 (fi) 1988-08-25
AU610558B2 (en) 1991-05-23
DE3881249D1 (en) 1993-07-01
EP0283742A3 (en) 1989-07-26
DK165406C (da) 1993-04-13
HK148195A (en) 1995-09-22
ATE89814T1 (de) 1993-06-15
IE59998B1 (en) 1994-05-18
US4716175A (en) 1987-12-29

Similar Documents

Publication Publication Date Title
US4716175B1 (cg-RX-API-DMAC10.html)
DE3661192D1 (en) Process for the preparation of alkyl esters of carboxylic acids, in particular of alkyl esters of fatty acids
GR3001523T3 (en) Substituted pyrimidine amides of oleic or linoleic acid as inhibitors of acyl-coa cholesterol acyltransferase
IL90413A (en) Process for the preparation of phosphorus-containing l-amino acids, their esters and n-derivatives and some novel intermediate compounds
AU2048288A (en) Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis
GB8803422D0 (en) Dimerised fatty acids having high content of dicarboxylic acid
PH21592A (en) Improved process for the non-degenerative destillation of fatty acids
EP0178106A3 (en) Enzymatic process
EP0430336A3 (en) Process for the preparation of 4-o-phosphates of dopamine and dopamine derivatives
DE3569931D1 (en) Carboxylic acid ester derivatives of deglucoteicoplanin
FR2580667B1 (fr) Procede de preparation enzymatique de l-amino acides renfermant du soufre
IL84426A (en) Process for the isolation of l-amino acids
PH23490A (en) Substituted anilides of oleic,linoleic,or linolenic acid as inhibitors of acyl-coa: cholesterol acyl transferase
IL72487A0 (en) Octahydroindolizinepropanoic acids and related compounds as enzyme inhibitors
AU610558C (en) Saturated fatty acid amides as inhibitors of acyl-coa: cholesterol acyltransferase
ZA886883B (en) Use of site-specific modified lipolytic enzymes for the selective hydrolysis of organized lipid structures
ZA815222B (en) Alpha-substituted ureidobenzylpenicillanic acid and process for the same
PT83775A (en) Process for the preparation of apovincaminic acid ethyl ester
BR8804533A (pt) Processo para preparacao de esteres de acidos 1-aril-pirazol-3-carboxilicos
FR2589151B1 (fr) Procede de preparation d'esters du diethyleneglycol
IL66000A0 (en) 4-hydroxyacetoacetic acid alkyl esters and process for their preparation
PL266437A1 (en) Method of obtaining ester softeners
TW330844B (en) Nutritional composition useful for inhibiting helicobacter
MY106260A (en) Liqiud detergent composition containing enzyme and enzyme stabilization system.
AU7958887A (en) Fatty esters of alkanolamine hydroxyalkylates as conditioners for oxidized coal